Brexit Committee hears from Aerospace, Chemicals and Pharmaceuticals sectors
29 September 2020
The Committee on the Future Relationship with the European Union returns on Wednesday 30 September with a virtual evidence session, examining how the end of the transition period will affect a trio of heavily regulated industries: Aerospace, Chemicals and Pharmaceticals.
- Watch Parliament TV: Progress of the negotiations on the UK’s Future Relationship with the EU
- Inquiry: Progress of the negotiations on the UK’s Future Relationship with the EU
- Committee on the Future Relationship with the European Union
In this evidence session, the Committee will consider the current operating and regulatory environment at EU and domestic level, the UK and EU's respective negotiating positions, and the implications of the two sides failing to reach an agreement. Witnesses are also expected to be questioned about the preparations they are undertaking as the transition period draws to a close.
The Committee will question representatives from ADS Group, the trade organisation representing the UK aerospace, defence, security and space industries, chemicals multinational BASF, and the Association of the British Pharmaceutical Industry.
Wednesday 30 September - remote participation by witnesses and Committee members
- Paul Everitt, Chief Executive, ADS Group
- Neil Hollis, Regulatory Affairs Manager, BASF
- Dr Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry